Package Leaflet: Information for the Patient
Mometasona Aristo50 micrograms/spray suspension for nasal spray
mometasone furoate
Read the package leaflet carefully before you start using this medicine because it contains important information for you.
Mometasona nasal spray suspension contains mometasone furoate, a medicine that belongs to a group of medicines called corticosteroids. When mometasone furoate is sprayed into the nose, it can help to relieve inflammation (swelling and irritation of the nose), sneezing, itching, and nasal congestion or discharge.
What is mometasone used for?
Hay fever and perennial rhinitis
Mometasone is used to treat the symptoms of hay fever (also known as seasonal allergic rhinitis) and perennial rhinitis in adults and children from 3 years of age.
Hay fever, which occurs at certain times of the year, is an allergic reaction caused by breathing in pollen from trees, grasses, weeds, and also mold and fungus spores. Perennial rhinitis occurs throughout the year and its symptoms can be due to sensitivity to various factors, such as house dust mites, animal hair (or dander), feathers, and certain foods. Mometasone reduces the inflammation and irritation of the nose and thus relieves sneezing, itching, and nasal congestion or discharge caused by hay fever or perennial rhinitis.
Nasal polyps
Mometasone is used to treat nasal polyps in adults over 18 years of age.
Nasal polyps are small growths in the lining of the nose and usually affect both nostrils. Mometasone reduces the inflammation of the nose, causing the polyps to shrink gradually, thus relieving the feeling of nasal congestion that can affect breathing through the nose.
Do not use Mometasona Aristo
Warnings and precautions
Consult your doctor or pharmacist before starting to use this medicine.
While you are using mometasone, consult your doctor
When corticosteroid nasal sprays are used at high doses for long periods of time, side effects can occur due to the medicine being absorbed into the body.
If you feel itching or irritation in the eyes, your doctor may recommend that you use other treatments with mometasone.
Contact your doctor if you experience blurred vision or other visual disturbances.
Children
When used at high doses for long periods of time, corticosteroid nasal sprays can cause side effects, such as slowing down the growth rate in children.
It is recommended to monitor the height of children on long-term treatment with nasal corticosteroids, and if any changes are noticed, you should inform your doctor.
Other medicines and mometasone
Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines, including those obtained without a prescription.
If you are taking other corticosteroids for allergies, either orally or by injection, your doctor may advise you to stop taking them once you start using this medicine. Some people may find that once they stop taking oral or injectable corticosteroids, they experience some side effects, such as muscle or joint pain, weakness, and depression. You may also develop other allergies, such as watery eyes, itchy eyes, or red, itchy rashes on the skin. If you develop any of these side effects, you should contact your doctor.
Some medicines may increase the effects of mometasone, and your doctor may monitor you closely if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).
Pregnancy and breastfeeding
There is little or no information on the use of mometasone in pregnant women. It is not known whether this medicine is excreted in breast milk.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
There is no known information on the effect of mometasone on driving or using machines.
This medicine contains benzalkonium chloride
Benzalkonium chloride may cause irritation or inflammation inside the nose, especially when used for long periods of treatment.
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again. Do not use higher doses or use the spray more often, or for longer than your doctor has told you.
Treatment of hay fever and perennial rhinitis
Use in adults and children over 12 years
The recommended dose is two sprays in each nostril once a day.
Use in children from 3 to 11 years
The recommended dose is one spray in each nostril once a day.
In some patients, mometasone starts to relieve symptoms within 12 hours of the first dose; however, it is unlikely that the optimal effect of treatment will be seen before the first two days. Therefore, you should continue to use the spray regularly to achieve the full benefit of treatment.
If you or your child suffer from severe hay fever, your doctor may advise you to start using mometasone a few days before the expected start of the pollen season, as this will help prevent the appearance of hay fever symptoms. At the end of the pollen season, the symptoms of hay fever should improve, and treatment may no longer be necessary.
Nasal polyps
Use in adults over 18 years
The usual initial dose is two sprays in each nostril once a day.
Preparing the nasal spray for use
Mometasona nasal spray has a dust cap that protects the nozzle and keeps it clean. Remember to remove it before using the spray and put it back on after use.
If you are going to use the spray for the first time, you need to "prime" the bottle by pressing the spray 10 times until a fine spray is produced:
If you have not used your nasal spray for 14 days or more, you need to "prime" the bottle again by pressing the spray 2 times until a fine spray is produced.
How to use your nasal spray
After using the spray, carefully clean the nozzle with a clean cloth or paper tissue and put the cap back on.
Cleaning your nasal spray
If you use more Mometasona Aristo than you should
Tell your doctor if you accidentally use more than prescribed.
If you use steroids for a long time or in large amounts, they can, in rare cases, affect some of your hormones. In children, this can affect growth and development.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Mometasona Aristo
If you forget to use your nasal spray at the right time, use it as soon as you remember, then follow your normal schedule of administration. Do not use a double dose to make up for forgotten doses.
If you stop treatment with Mometasona Aristo
In some patients, mometasone starts to relieve symptoms 12 hours after the first dose; however, the full benefit of treatment may not be seen until two days later. It is very important that you use your nasal spray regularly. Do not stop your treatment even if you feel better, unless your doctor tells you to.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Immediate hypersensitivity reactions (allergic reactions) can occur after using this medicine. These reactions can be serious. You should stop treatment with mometasone and seek medical help immediately if you experience symptoms such as:
If corticosteroid nasal sprays are used at high doses for long periods of time, side effects can occur due to the medicine being absorbed into the body.
Other side effects
Most people do not have any problems after using the nasal spray. However, some people after using mometasone or other corticosteroid nasal sprays may experience:
Common side effects (may affect up to 1 in 10 people)
Frequency not known (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency's Pharmacovigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and bottle after "EXP". The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions. Do not freeze.
The spray should be used within 8 weeks of first use.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE point. If you are unsure, ask your pharmacist how to dispose of the packaging and unused medicine. This will help protect the environment.
Appearance of the product and pack contents
Mometasona Aristo is a nasal spray suspension and is presented in a white high-density polyethylene bottle, which contains 10 g (60 sprays) or 18 g (140 sprays) of the product formulation, supplied with a manual pump sprayer made of polypropylene, calibrated dose.
The 60-spray bottles are supplied in individual packs.
The 140-spray bottles are supplied in packs of 1 or 3 nasal sprays.
Not all pack sizes may be marketed.
Marketing authorisation holder
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
Manufacturer
Teva Czech Industries s.r.o.
Ostravská 305/29, Komárov,
747 70 Opava
Czech Republic
You can obtain further information on this medicine by contacting the local representative of the marketing authorisation holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medicine is authorised in the Member States of the European Economic Area under the following names:
Denmark Mometasonfuroat Aristo 50 mikrogram/dosis næsespray, suspension
Germany Mometason Aristo 50 Mikrogramm / Sprühstoß Nasenspray, Suspension
Norway Mometasone Aristo 50 mikrogram/dose nesespray, suspensjon
Spain Mometasona Aristo 50 micrograms suspension for nasal spray
Date of last revision of this leaflet: February 2024
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/